Mikael Tinglöf

Mikael Tinglöf, listed as board member, appears in our data through filings on Vaxxa AB shares, published by Finansinspektionen. Over a trading history stretching from 24 August 2023 to 29 July 2025, the count stands at 10 filings.

Both buying and selling appear: 4 purchases worth €33k, against 4 sales worth €8,589. Netting one side against the other leaves €25k of net buying. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 3 purchases and 4 sales.

The median purchase comes to €10k. Of 4 purchases, 1 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 29 July 2025, reports an open-market purchase of €691 in Vaxxa AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.